Highlights Addex Therapeutics Ltd Nasdaq

Equities

Market Closed - Nasdaq Other stock markets 07:15:19 25/06/2024 pm IST			5-day change	1st Jan Change
7.98 ^USD	+3.64%		-2.09%	+31.90%

06/06	Transcript : Addex Therapeutics Ltd, Q1 2024 Earnings Call, Jun 06, 2024
06/06	Addex Therapeutics' Q1 Net Loss Widens; Revenue Down	MT

Addex Therapeutics' Q1 Net Loss Widens; Revenue Down	06/06	MT
European Equities Traded in the US as American Depositary Receipts Decline	30/04	MT
Sector Update: Health Care Stocks Edge Higher Late Afternoon	30/04	MT
Sector Update: Health Care	30/04	MT
Top Midday Decliners	30/04	MT
Addex Therapeutics Shares Plunge as Phase 2 Study of ADX71149 Falls Short of Primary Goal	29/04	MT
Tech Rally Subsides as US Equity Futures Waver Pre-Bell	29/04	MT
Top Premarket Decliners	29/04	MT
Addex Therapeutics Shares Plunge Premarket on Epilepsy Study Failure	29/04	DJ
Addex Provides Update on ADX71149 Phase 2 Epilepsy Study	29/04	CI
Addex Therapeutics Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	18/04	CI
Addex Therapeutics Logs Decline in FY23 Net Loss; Revenue Rises	18/04	MT
Addex Therapeutics Reports Full Year 2023 Financial Results and Provides Corporate Update	18/04	DJ
ADRs End Higher; Biophytis Climbs 30%	10/04	DJ
Wall Street Set to Open Slightly Higher as Investors Await Wednesday's Inflation Data	09/04	MT
Top Premarket Gainers	09/04	MT
ADRs Advance, Eco Wave Power Global AB Climbs 213.4%	09/04	DJ
Top Premarket Gainers	03/04	MT
Addex Therapeutics Announces the Launch of Neurosterix, Company Focused on Developing Allosteric Modulators for the Treatment of Underserved Neurological Disorders	03/04	CI
Addex and Perceptive Launch Neurosterix with $63 Million to Accelerate Development of Allosteric Modulator Therapeutics for Neurological Disorders	03/04	DJ

No results for this search